Anticancer Properties of Indole Derivatives as IsoCombretastatin A-4 analogues - Archive ouverte HAL
Article Dans Une Revue European Journal of Medicinal Chemistry Année : 2021

Anticancer Properties of Indole Derivatives as IsoCombretastatin A-4 analogues

Résumé

In this study, a variety of original ligands related to Combretastatin A-4 and isoCombretastatin A-4, able to inhibit the tubulin polymerization into microtubules, was designed, synthesized, and evaluated. Our lead compound 15d having a quinazoline as A-ring and a 2-substituted indole as Bring separated by a N-methyl linker displayed a remarkable subnanomolar level of cytotoxicity (IC 50 < 1 nM) against 9 human cancer cell lines.
Fichier principal
Vignette du fichier
EJMC final indoles.pdf (1.34 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03349143 , version 1 (20-09-2021)

Identifiants

Citer

Shannon Pecnard, Abdallah Hamze, Jérome Bignon, Bastien Prost, Alain Deroussent, et al.. Anticancer Properties of Indole Derivatives as IsoCombretastatin A-4 analogues. European Journal of Medicinal Chemistry, 2021, 223, pp.113656. ⟨10.1016/j.ejmech.2021.113656⟩. ⟨hal-03349143⟩
45 Consultations
204 Téléchargements

Altmetric

Partager

More